Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Cusatuzumab (Anti-TNFSF7 / CD27L / CD70) For research use only.
Not for use in humans.

Cusatuzumab (Anti-TNFSF7 / CD27L / CD70)

Synonyms:

Cusatuzumab (Anti-TNFSF7 / CD27L / CD70) is a defucosylated, humanized IgG1 monoclonal antibody directed against the extracellular domain of the human CD70 molecule with potential antineoplastic activity. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML). MW: 144.36 kD.

Cusatuzumab (Anti-TNFSF7 / CD27L / CD70)

Purity & Quality Control

Batch: A274701 Purity: 99% Protein concentration: 10.72mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Cusatuzumab (Anti-TNFSF7 / CD27L / CD70) is a defucosylated, humanized IgG1 monoclonal antibody directed against the extracellular domain of the human CD70 molecule with potential antineoplastic activity. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML). MW: 144.36 kD.

Product Details

CAS No. 1399546-01-0
Molecular Weight 144.36
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Cusatuzumab (Anti-TNFSF7 / CD27L / CD70) | Cusatuzumab (Anti-TNFSF7 / CD27L / CD70) supplier | purchase Cusatuzumab (Anti-TNFSF7 / CD27L / CD70) | Cusatuzumab (Anti-TNFSF7 / CD27L / CD70) cost | Cusatuzumab (Anti-TNFSF7 / CD27L / CD70) manufacturer | order Cusatuzumab (Anti-TNFSF7 / CD27L / CD70) | Cusatuzumab (Anti-TNFSF7 / CD27L / CD70) distributor